SABBY MANAGEMENT, LLC - NEUROBO PHARMACEUTICALS INC ownership

NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 22 filers reported holding NEUROBO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$45,000
-86.6%
93,376
-75.0%
0.03%
-38.0%
Q1 2022$337,000
-60.9%
373,111
-47.2%
0.05%
-60.0%
Q4 2021$862,000
+15.2%
706,946
+396.5%
0.12%
-12.6%
Q4 2020$748,000
-27.1%
142,400
-22.0%
0.14%
-6.5%
Q3 2020$1,026,000
-45.2%
182,543
-21.5%
0.15%
-59.3%
Q2 2020$1,872,000232,5470.38%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Hayden Royal, LLC 20,642$91,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 173,202$762,0000.01%
SG3 Management, LLC 50,000$220,0000.01%
Ameritas Investment Partners, Inc. 378$2,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 9,817$43,0000.00%
UBS Group AG 2,841$13,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 3,926$17,0000.00%
BANK OF AMERICA CORP /DE/ 11,642$51,0000.00%
WELLS FARGO & COMPANY/MN 13,762$61,0000.00%
NORTHERN TRUST CORP 78,993$348,0000.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders